Arterially directed therapies for hepatocellular carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21940531.
- Also identified by DOI 10.2214/AJR.11.7554.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Arterially directed therapies for hepatocellular carcinoma are used for patients who are not candidates for surgery or ablation and for those who need a bridge or down-staging to liver transplantation. These therapies seem to prolong the overall survival when compared with supportive care. Chemoembolization, particle embolization, drug-eluting beads, and radioembolization have been used for locoregional control. This review discusses patient selection, techniques, safety, clinical outcomes, and imaging findings related to these therapies.
Medical subject headings
- Carcinoma, Hepatocellular
- Embolization, Therapeutic
- Liver Neoplasms
- Neoplasm Staging